Background: Hematological abnormalities are frequently found in geriatric patients. However, little data is available on reference values for total blood cell counts in older patients. This study is focused on the analysis of reference values for white blood cell counts in aged persons ≥60 years. Methods: This was a cross-sectional study of outpatient laboratory data of 2015 from a German countrywide working laboratory company; inclusion criteria: age ≥60 years, parameters evaluated by the laboratory company between 1.1.2015 and 31.12.2015; exclusion criteria: glomerular filtration rate (GFR) <60 mL/min, lack of inclusion criteria; primary objective: mean leukocyte count; secondary objective: mean counts of lymphocytes, eosinophil, neutrophil and basophil leukocytes as well as platelets, C-reactive protein (CRP), γ-glutamyl transferase (GGT) and lactate dehydrogenase (LDH) in hematologically healthy persons aged ≥60 years. Results: Data of 30,611 persons aged ≥60 years were evaluated by age groups. Results for leukocytes, basophils, eosinophils, neutrophils and lymphocytes remained within the reference ranges recommended by the German Society of Hematology and Oncology (DGHO) and the
Introduction
Laboratory results are important for diagnostic, therapeutic and prognostic decision-making in clinical practice. Correct interpretation of laboratory results, however, is only possible if accurate reference values are provided. Despite the large amount of health care resources spent on the growing number of geriatric patients, there is still a lack of accurate reference values and age adjusted reference limits for laboratory parameters. This is mainly due to the fact that laboratory reference values are established based on samples from evidently healthy individuals, commonly aged <60 years [1] . Although older patients are meanwhile conceded to be an own entity with a distinct biology, reference intervals derived from younger individuals are still commonly used in geriatric patients [2] . The application of unsuitable reference values, however, is associated with the risk of misinterpretation of clinical conditions, resulting in inadequate, often time-consuming and expensive treatment [3] . Data on reference values for laboratory parameters in geriatric patients are still scarce. With the exception of the results obtained within the Canadian Health Measure Survey [4, 5] and the initiation of the Swiss SENIORLAB observational study [3] , the majority of studies in this field are either limited to small cohorts [6] or have been published more than 10 years ago [7] . German data on reference ranges for older patients are still scarce and often limited to regional evaluations [8] . Recently, we published the first nationwide analysis on erythrocytic parameters among a large cohort of hematologically healthy German seniors [9] . Based on this large database, we now evaluated the laboratory parameters of white blood cell counts, platelets and anemia-related parameters among obviously hematologically healthy German subjects aged 60 years or older.
The primary objective of this evaluation was the determination of age-specific reference limits for leukocyte values of study subjects ≥60 years of age. The secondary objective was the determination of age-specific reference limits for white blood cell subgroups (lymphocytes, monocytes; eosinophilic, basophilic and neutrophilic granulocytes), platelets and anemia-related parameters like ferritin, transferrin saturation, soluble transferrin receptor (sTR), C-reactive protein (CRP), lactate dehydrogenase (LDH), γ-glutamyl transferase (GGT), haptoglobin and bilirubin.
This study is registered in the German Clinical Trials Registry (DRKS, Freiburg) with no. DRKS00008792. The Ethics Committee of the University Hospital Cologne approved the study (no. 15-282; 27.10.2015) . The study was carried out in accordance with the current version of the Declaration of Helsinki of 2013.
Subjects and methods
The analysis was based on a cross-sectional study design. Methods have been previously described elsewhere [9] . We evaluated anemia-related laboratory data of 30,611 outpatients aged ≥60 years from a German nationwide acting laboratory group, not limited to hematologic analysis. The interval of data collection was 12 months, from January 1 st , 2015 to December 31 st , 2015. All measurements were performed on Sysmex XN 9000 hematology analyzers (Norderstedt, Germany). There was no switch of laboratory device during the time of data collection.
Initially available anemia-related laboratory data included red and white blood cell counts with subtypes, platelets, reticulocytes, CRP, ferritin, glomerular filtration rate (GFR), transaminases and GGT, haptoglobin, LDH, transferrin and transferrin saturation, transferrin receptor, vitamin B12 and folic acid. After the previous analysis of red blood cells and erythrocytic indices [9] , the focus of the present study was on the analysis of white blood cells, platelets and anemia-related biochemical parameters. Study parameters therefore included white blood cell counts with subtypes, platelets, CRP, ferritin, GFR, transaminases and GGT, haptoglobin, LDH, transferrin and transferrin saturation and sTR. For the evaluation of reference values of healthy subjects aged ≥60 years, we selected for the analysis of each laboratory value only subjects who showed no deviation from the given reference ranges in all other anemia-related parameters (=inclusion criteria). Reference ranges were based on the recommendations by the German Society of Hematology and Oncology (Deutsche Gesellschaft für Hämatologie und internistische Onkologie, DGHO) [10, 11] .
Exclusion criteria were reduced GFR (mL/min) estimated based on the Chronic Kidney Disease Epidemiology Collaboration (CKD-Epi) formula for subjects ≤70 years of age (reference value ≥90 mL/min) [12] and for subjects >70 years of age estimated based on the Berlin Initiative Study (BIS) formula (reference value ≥60 mL/min) [8, 13] .
Subjects included in the study according to inclusion and exclusion criteria were considered hematologically healthy. For age-specific analysis, age groups were formed by age decades as 60-69 years, 70-79 years, 80-89 years and ≥90 years.
Laboratory data were described by mean, standard deviation (STD), median, 2.5 th (P2.5) and 97.5 th (P97.5) percentiles, minimal and maximal values. Percentiles, together with nonparametric 95% confidence intervals (CIs) by normal approximation [10] , were calculated according to the International Federation of Clinical Chemistry guidelines on the statistical treatment of reference values [14] . The distribution of laboratory data was compared between the age groups using KolmogorovSmirnov tests.
CRP values less than or equal to 5 mg/L could not be distinguished by the laboratory and were presented as "<5 mg/L". These definitions were set to the value 1 for calculations.
Results of the study were descriptively compared with established reference values issued by medical expert associations like the German Association of Specialists in Internal Medicine [15] (Berufsverband Deutscher Internisten, BDI) for leukocytes, LDH, GGT and CRP, and the DGHO [16] for platelets, neutrophil, eosinophil, basophil leukocytes, monocytes and lymphocytes. For CRP, GGT and LDH, reference limits could be compared with the results of Carlsson et al. [17] by CIs.
All authors have complied with the World Medical Association Declaration of Helsinki regarding ethical conduct of research involving human subjects and/or animals.
Results
Of 30,611 cases, we excluded 207 cases for lack of blood cell counts. After application of inclusion and exclusion criteria, analysis of white blood cell counts, platelets and anemia-related parameters was performed among the remaining subjects. Due to the cross-sectional character of the study, not all parameters were sufficiently available for statistical analysis. Therefore, only the following parameters remained for evaluation: leukocytes with subtypes of lymphocyte, monocytes, eosinophils, basophils, neutrophils, platelets, CRP, LDH and GGT. With regard to the nonagenarians, however, statistical power is limited due to the very small number of subjects in this age decade. Nevertheless, for the sake of completeness, results are presented. Tables 1-10 show the descriptive results of all laboratory data by gender and age decade.
Comparison of 2.5 th to 97.5 th percentile value of study parameters with the recommended DGHO reference ranges [16] for the study parameters revealed accordance with basophil, eosinophil and neutrophil leukocytes as well as lymphocytes (Table 11 ). In platelets, however, the lower reference limit for normal platelet values in males was below the DGHO reference values with 136,000 (CI 129,000;142,000). In monocytes, our results were above the DGHO reference values with 6.0 (5.7;6.2) to 14.3 (13.9;14.8) in males and 5.4 (5.2;5.6) to 12.9 (12.6;13.4) in females (Table 11) . CRP, GGT and LDH values were above the BDI reference values, comparable with the previous data of a senior patient cohort analysis [17] (Table 11) .
We additionally compared the complete distribution between males and females and among age groups based on the Kolmogorov-Smirnov test. There was no significant difference revealed except for platelets: they were significantly lower in males than in females (p < 0.001) and significantly declined over age decades (p < 0.001). The correlation analysis of mean cell volume (MCV) and platelets did not reveal any association (r = − 0.06).
Discussion
The aim of the study was the analysis of laboratory blood parameters of hematologically healthy patients aged 60 years or older to assess normal value ranges and check for deviation from established reference values issued by medical expert associations.
The results of our analysis revealed that the leukocyte levels remained within the reference interval recommended by the BDI. For the leukocyte subtypes eosinophils, basophils, neutrophils (without differentiation between the segmented and the core type in our study) and lymphocytes, the reference intervals found in Carlsson et al. [17] this study group were also in accordance with the reference values of younger patients as recommended by the DGHO and the BDI. For monocytes, however, our study revealed higher upper limits than those recommended by the DGHO. Given the fact that monocytes play a central role in both the initiation and resolution of inflammation [18] and are subject to immunosenescence [19] , this finding might point to the age-associated process of inflammation, called "inflamm-aging" [20] . This idea is supported by our finding of elevated CRP values in this study group: the results showed no clinically relevant difference between gender age groups, while comparison with younger patients (BDI) revealed that the upper limits in this aged patient group were elevated. This finding is in accordance with the results by Carlsson et al. [17] , who analyzed laboratory parameters like CRP among Swedish persons aged ≥70 years [17] . Given the fact that values of monocytes in this hematologically healthy patient group are also higher than the reference values among younger patients [15, 16] , these findings might possibly point to this age-associated underlying chronic low-grade inflammation with increased levels of proinflammatory cytokines [21] , which is meanwhile widely acknowledged to occur with rising age [22] . Interestingly, Leng et al. reported similar findings in their study group of frail older women, revealing elevated white blood cell counts, albeit under the upper limit of the normal range referred to, but associated with elevated counts of monocytes [23, 24] . The upregulation of monocytes has been supposed to be a response to the activation of an inflammatory pathway, a molecular mechanism leading to chronic inflammation, which is a risk factor for frailty [25] . Additionally, previous studies have also shown an association between elevated inflammatory molecules like CRP and frailty syndrome in older patients [26] . As the inclusion criteria of this study were intended to select hematologically healthy seniors, no reliable estimation about the frailty status can be made. If elevated levels of inflammatory molecules and cells might be precursors of a developing frailty syndrome remains speculative and should be subject to further studies. Based on these findings, one can conclude that laboratory test results for CRP and monocytes should be interpreted carefully and depending on patients' age. Thus, the establishment of age-dependent reference values is required.
In our patient group, platelet values were higher in women than in men and significantly decreased (p < 0.001) among men with rising age. This finding is in accordance with a previous Italian study on age-and gender-related changes in platelet counts [27] . The study group concluded that laboratory reference values should be adapted to age classes with estimated levels of 122-350,000/μL for older men and 140-379,000/μL for older women [27] . The reason for this age-associated decline of platelets is still unclear. In a recent review, Jones addressed these gaps to our knowledge about decline, function and biochemical changes in platelets of patients aged >75 years [28] . While there are sufficient data about platelet count, function and platelet biochemistry derived from younger patients, a reliable database for geriatric patients aged >75 years is lacking. Our results are in accordance with these previous findings and underline the recommendation of adapting laboratory platelet reference values to older age [27, 28] . An association between platelets and MCV, typical for myelodysplastic syndromes, was not seen in this patient cohort [29] . The finding of an age-associated decline of platelets in men will be of particular clinical importance in connection with polymedication and drug-induced thrombocytopenia in geriatric patients [30] . However, further research is needed before general recommendations can be given.
In our study, women had lower, but not significantly lower, GGT values than men. The upper limit of GGT values is higher in this aged study group than that recommended by the BDI [15] . Our results, however, are in accordance with the results of a Swedish study research group, revealing higher limits of GGT among their study patients aged ≥70 years [17] . A possible explanation for this finding might be found when considering the role of GGT as a cardiovascular risk factor and its association with increased risk of fatal outcome in chronic heart failure patients [31] . Comorbidity of our study patients remains unclear and inclusion in the study only required lack of hematological disease. Given the increasing prevalence of cardiovascular comorbidity with rising age, the elevated GGT levels in this study group may suggest an association. It would be of interest to study GGT levels in aged patients without cardiovascular disease.
Interestingly, in our study group, the upper limits of LDH were higher than in the younger patients (BDI) and also higher than in the Swedish peer group [17] . The reason for this finding remains unclear, but comorbidity (e.g. skeletal muscle or cancer disease) might play a role, as our patients had only been selected to be hematologically healthy.
Our study has some limitations: Due to the crosssectional character, data for statistical evaluation were not available for all study parameters. Additionally, we did not get any information about patients' smoking habits, medication or comorbidities which might have a negative impact on study parameters.
The virtues of our study are the large number of patients and the unique character, because there have not been any comparably large evaluations on aged persons in Germany before.
Our findings underline that some laboratory parameters seem to be age-dependent and change with growing older. Others, however, like leukocytes and leukocyte subtypes (except monocytes) seem to remain stable independent of age. The adaptation of reference values for selected laboratory parameters like platelets (in men), monocytes, CRP, GGT and LDH in older German patients should be well considered and patients' age and comorbidity should be taken into account for the interpretation of laboratory test results.
